Expiratory ventilatory capacity measurements in children with cystic fibrosis treated by oral acetylcysteine.
D000111:Acetylcysteine / Q000627:therapeutic use*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002233:Carbocysteine / Q000627:therapeutic use; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D005540:Forced Expiratory Flow Rates; D006801:Humans; D008297:Male; D010366:Peak Expiratory Flow Rate; D013997:Time Factors; D014797:Vital Capacity
D002233:Carbocysteine; D000111:Acetylcysteine